PEDIATRICS Vol. 115 No. 6 June 2005, pp. 1494-1500 (doi:10.1542/peds.2004-1425)
Morphine Does Not Provide Adequate Analgesia for Acute Procedural Pain Among Preterm Neonates
* Neonatal Intensive Care Unit, Poissy Saint Germain Hospital, Poissy, France
Centre National de Ressources de Lutte Contre la Douleur, Hôpital d’Enfants Armand Trousseau, Paris, France
Maryland Medical Research Institute, Baltimore, Maryland
|| University of Arkansas for Medical Sciences, Arkansas Children’s Hospital, Little Rock, Arkansas
Background. Morphine alleviates prolonged pain, reduces behavioral and hormonal stress responses induced by surgery among term neonates, and improves ventilator synchrony and sedation among ventilated preterm neonates, but its analgesic effects on the acute pain caused by invasive procedures remain unclear.
Objective. To investigate the analgesic efficacy of intravenously administered morphine on heel stick-induced acute pain among preterm neonates.
Design. This study was nested within a prospective, randomized, double-blind, multicenter, placebo-controlled trial (the NEOPAIN Trial).
Setting. A tertiary-care NICU in a teaching hospital.
Participants. Forty-two preterm neonates undergoing ventilation.
Interventions. Neonates were randomized to either the morphine (loading dose of 100 µg/kg, followed by infusions of 10–30 µg/kg per hour according to gestation, N = 21) or placebo (5% dextrose infusions, N = 21) group. Pain responses to 3 heel sticks were evaluated, ie, before the loading dose (T1), 2 to 3 hours after the loading dose (T2), and 20 to 28 hours after the loading dose (T3).
Main Outcomes Measures. Pain was assessed with the Douleur Aiguë Nouveau-né (DAN) scale (behavioral pain scale) and the Premature Infant Pain Profile (PIPP) (multidimensional pain scale); plasma morphine levels were measured at T3.
Results. Infants in the placebo and morphine groups had similar gestational ages (mean ± SD: 27.2 ± 1.7 vs 27.3 ± 1.8 weeks) and birth weights (972 ± 270 vs 947 ± 269 g). Mean ± SD DAN pain scores at T1, T2, and T3 were 4.8 ± 4.0, 4.6 ± 2.9, and 4.7 ± 3.6, respectively, for the placebo group and 4.5 ± 3.8, 4.4 ± 3.7, and 3.1 ± 3.4 for the morphine group. The within-group factor (pain at T1, T2, and T3) was not statistically different over time. The between-group analysis (infants receiving placebo versus those receiving morphine) showed no significant differences. Mean ± SD PIPP pain scores at T1, T2, and T3 were 11.5 ± 4.8, 11.1 ± 3.7, and 9.1 ± 4.0, respectively, for the placebo group and 10.0 ± 3.6, 8.8 ± 4.9, and 7.8 ± 3.6 for the morphine group. The within-group factor was statistically different over time. The between-group analysis showed no significant differences. Mean ± SD plasma morphine levels at T3 were 0.44 ± 1.79 ng/mL and 63.36 ± 33.35 ng/mL for the placebo and morphine groups, respectively. There was no correlation between plasma morphine levels and pain scores at T3 (DAN, R = –0.05; PIPP, R = –0.02).
Conclusions. Despite its routine use in the NICU, morphine given as a loading dose followed by continuous intravenous infusions does not appear to provide adequate analgesia for the acute pain caused by invasive procedures among ventilated preterm neonates.
Key Words: morphine • pain • neonates • analgesia • procedures
Abbreviations: PIPP, Premature Infant Pain Profile • DAN, Douleur Aiguë Nouveau-né • RCT, randomized, controlled trial
Accepted Nov 16, 2004.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Carbajal and K. J. S. Anand Prevention of Pain in Neonates--Reply JAMA, November 19, 2008; 300(19): 2248 - 2249. [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. S. Anand, B. J. Anderson, N. H. G. Holford, R. W. Hall, T. Young, B. Shephard, N. S. Desai, B. A. Barton, and for the NEOPAIN Trial Investigators Group Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trial Br. J. Anaesth., November 1, 2008; 101(5): 680 - 689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Carbajal, A. Rousset, C. Danan, S. Coquery, P. Nolent, S. Ducrocq, C. Saizou, A. Lapillonne, M. Granier, P. Durand, et al. Epidemiology and Treatment of Painful Procedures in Neonates in Intensive Care Units JAMA, July 2, 2008; 300(1): 60 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.J.S. Anand MBBS DPhil Analgesia for skin-breaking procedures in newborns and children: What works best? Can. Med. Assoc. J., July 1, 2008; 179(1): 11 - 12. [Full Text] [PDF]
|
|
|
|
|
|
S. M. Walker Pain in children: recent advances and ongoing challenges Br. J. Anaesth., July 1, 2008; 101(1): 101 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J E. Harrop Management of pain in childhood Arch. Dis. Child. Ed. Pract., August 1, 2007; 92(4): ep101 - ep108. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ghanta, M. E. Abdel-Latif, K. Lui, H. Ravindranathan, J. Awad, and J. Oei Propofol Compared With the Morphine, Atropine, and Suxamethonium Regimen as Induction Agents for Neonatal Endotracheal Intubation: A Randomized, Controlled Trial Pediatrics, June 1, 2007; 119(6): e1248 - e1255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. S. Anand Pain Assessment in Preterm Neonates Pediatrics, March 1, 2007; 119(3): 605 - 607. [Full Text] [PDF]
|
|
|
|
 |
|
 K J S Anand and R W Hall Pharmacological therapy for analgesia and sedation in the newborn. Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2006; 91(6): F448 - F453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Slater, A. Cantarella, S. Gallella, A. Worley, S. Boyd, J. Meek, and M. Fitzgerald Cortical pain responses in human infants. J. Neurosci., April 5, 2006; 26(14): 3662 - 3666. [Abstract] [Full Text] [PDF]
|
|
